{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:36Z","timestamp":1792511316841,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":568,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jtct.2021.07.024","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T13:18:30Z","timestamp":1627564710000},"page":"949.e1-949.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"Hiroyuki","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Imataki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko Hamasaki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.07.024_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1705023","article-title":"Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients","volume":"36","author":"Rhodes","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/petr.12062","article-title":"Pericardial effusion after pediatric hematopoietic cell transplant","volume":"17","author":"Aldoss","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0003","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bmt.2010.297","article-title":"Large pericardial effusion as a complication in adults undergoing SCT","volume":"46","author":"Norkin","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0004","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bmt.2015.227","article-title":"Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant","volume":"51","author":"Chen","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bjh.13357","article-title":"Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation","volume":"169","author":"Liu","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.07.024_bib0006","doi-asserted-by":"crossref","first-page":"e13748","DOI":"10.1111\/petr.13748","article-title":"Pericardial effusion following hematopoietic stem cell transplantation in children: incidence, risk factors, and outcomes","volume":"24","author":"Tinianow","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0007","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bmt.2010.149","article-title":"Pericardial effusion post-SCT in pediatric recipients with signs and\/or symptoms of cardiac disease","volume":"46","author":"Neier","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00246-017-1747-x","article-title":"Predictors and outcome of pericardial effusion after hematopoietic stem cell transplantation in children","volume":"39","author":"Versluys","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jtct.2021.07.024_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MPH.0000000000000974","article-title":"Incidence and outcome of pericardial effusion in pediatric patients after hematopoietic stem cell transplant: a single-institution experience","volume":"40","author":"Diamond","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2021.07.024_bib0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bbmt.2017.03.028","article-title":"Pericardial effusion following hematopoietic cell transplantation in children and young adults is associated with increased risk of mortality","volume":"23","author":"Cox","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0011","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/tri.12532","article-title":"Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtct.2021.07.024_bib0012","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bmt.2015.105","article-title":"Chronic GvHD-associated serositis and pericarditis","volume":"50","author":"Leonard","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0013","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0015","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.024_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.07.024_bib0017","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0018","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2021.07.024_bib0021","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.07.024_bib0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0023","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.07.024_bib0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.07.024_bib0026","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1703271","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0027","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0028","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bmt.2014.40","article-title":"Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy","volume":"49","author":"Lerner","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.024_bib0029","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1177\/0963689717727285","article-title":"Factors affecting survival in children with pericardial effusion after hematopoietic stem cell transplantation","volume":"26","author":"Jaing","year":"2017","journal-title":"Cell Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721011064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721011064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:08:06Z","timestamp":1763003286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721011064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2666636721011064"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.024","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}